Health Care/Hospital

WuXi PharmaTech Starts Moving Scientists to New Facility

SHANGHAI, China, Jan. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has begun moving the first group of scientists to its state-of-the-art Tianjin research facility, which first became operational in De...

2007-01-16 21:08 870

'Pulse On America' Show to Feature Global Pharmatech

Thursday, January 11, 2007 8:30 ET JILIN, China, Jan. 11 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP; the "Company") a company that develops, manufactures and markets proprietary botanical drugs and dietary supplements, announced that it will be featured in Platin...

2007-01-11 21:30 878

ChemBridge Announces Their New Fragment Library for Screening

SAN DIEGO, Jan. 10 /Xinhua-PRNewswire/ -- ChemBridge has assembled an exemplary collection of small molecules useful for fragment-based screening: the new Fragment Library. The emergence and development of high throughput X-ray crystallography and NMR methodologies for drug discovery have contr...

2007-01-10 20:00 1018

WHO Plans to Increase Treatment Access for Victims of Rabies and Snake Bites

GENEVA, Jan. 10 /Xinhua-PRNewswire/ -- Although more than 12 million people each year are bitten by dogs or snakes, or stung by scorpions, the world's capacity to treat them is inadequate. Effective treatment for these conditions is critically dependent on therapeutic sera*, but this essential ...

2007-01-10 12:05 858

Organon Partners With HUYA to Identify and Develop Chinese Biopharmaceuticals

Collaboration Looks for Opportunities to Expand the Organon Biotech Research Programs and Facilitate Links With China's Biotech Industry OSS, Netherlands and SAN DIEGO, Jan. 9 /Xinhua-PRNewswire/ -- Organon, the human healthcare business of Akzo Nobel (Nasdaq: AKZOY), announced today that i...

2007-01-09 21:00 871

TaiGen Initiates Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)

TAIPEI, Taiwan, Jan. 8 /Xinhua-PRNewswire/ -- TaiGen Biotechnology Inc. announced today that the company has started enrollment of patients for the Phase II clinical trial of Nemonoxacin (TG-873870) for the treatment of adult community acquired pneumonia (CAP). The randomized, double-blind, c...

2007-01-08 21:30 705

China Health Holding Announces Acquisition of All of the Assets of Xi’An Meichen Pharmaceutical

LAS VEGAS, Jan. 8 /Xinhua-PRNewswire-FirstCall/ -- China Health Holding, Inc. (OTC Bulletin Board: CHHH), a development stage company with the goal of becoming a developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide, anno...

2007-01-08 23:08 806

GfK HealthCare Asia Concludes Prescription Drug Pilot

New Service Shows Complete Picture of Pharmaceutical Sales Force with the addition of prescription tracking SINGAPORE and HONG KONG /Xinhua-PRNewswire/ -- GfK HealthCare Asia has concluded two highly successful pilots for its Sales Force Effectiveness (SFE) program, a...

2007-01-08 13:30 979

sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006

Record Production Capabilities Strengthen sanofi pasteur’s Global Leadership in the Fight Against Seasonal Influenza and Place the Company at the Forefront of Pandemic Readiness LYON, France and SWIFTWATER, Pa., Jan. 8 /Xinhua-PRNewswire/ -- sanofi pasteur, the vaccines business of the sano...

2007-01-08 09:54 837

New Chinese Policy to Benefit Global Pharmatech

JILIN, China, Jan. 4 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP.OB) a company that develops, manufactures and markets proprietary botanical drugs and dietary supplements, announced that the Chinese State Food and Drug Administration (SFDA), has...

2007-01-04 23:00 1005

Dr Margaret Chan Takes Office as Director-General of the World Health Organization

Impact on Health of Women and People in Africa to Be Measure of Success GENEVA, Jan. 4 /Xinhua-PRNewswire/ -- Dr Margaret Chan of China today took office as Director-General of the World Health Organization (WHO) following her election in November. She pledged that her term of office and t...

2007-01-04 19:44 911

AIDS Healthcare Foundation Announces New AIDS Treatment & Training Partnership in Xinjiang Province, China

AIDS Healthcare Foundation Joins Together With China's Xinjiang Medical University to Roll-Out the 'AHF - Xinjiang Medical University-Affiliated Hospital HIV/AIDS Treatment & Training Initiative' Partnership Between US' Largest AIDS Group and Respected Chinese Institutions Seek to Create a 'Cen...

2007-01-04 22:30 824

Gerresheimer Group Acquires European Market Leader for Medical Plastic Systems

-- With the Wilden Group Gerresheimer is Also Market Leader for Plastic Systems -- Gerresheimer CEO Dr. Axel Herberg: 'A giant step in our growth strategy' DUSSELDORF, Germany, Jan. 3 /Xinhua-PRNewswire/ -- A key chapter is added to the growth story of the Ger...

2007-01-03 14:00 1076

Global Pharmatech Announces Results of Annual Shareholders' Meeting

JILIN, China, Dec. 27 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP; the "Company") a company that develops, manufactures and markets proprietary botanical drugs and dietary supplements, today announced the results of its annual shareholders' meeting. (Logo: h...

2006-12-27 21:30 891

US Patent Granted to ScinoPharm for the Production of SN-38

TAINAN, Taiwan, Dec. 20 /Xinhua-PRNewswire/ -- ScinoPharm has just been awarded an US patent that relates to the preparation of SN-38, a key intermediate in the synthesis of irinotecan. The US patent, No. 7,151,179, entitled "Process for the Preparation of 7-Alkyl-10-Hydroxy-20(S)- Campt...

2006-12-20 19:20 904

Winner Medical Group Reports Fourth Quarter and Year End Fiscal 2006 Results

SHENZHEN CITY, China, Dec. 20 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), today reported financial results for the fourth quarter and fiscal year ended September 30, 2006. Revenues for the fourth fiscal quarter were $16.64 million compared to $18.56 mil...

2006-12-20 05:01 913

BioVision 2007, the World Life Sciences Forum, Set to Tackle Some of Today’s Most Critical Health, Nutrition and Environmental Issues

-- The 5th edition of BioVision (March 11 - 14, 2007 in Lyon, France) will gather leading international experts on health, nutrition and environment issues to discuss, debate and agree actions for change. LYON, France, Dec. 20 /Xinhua-PRNewswire/ -- BioVision today confirmed its broad...

2006-12-20 18:52 896

MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With BioWa

- Initial Focus on Monoclonal Antibody Targeting IL-5 Receptor in Phase 1 Trials with Asthma Patients - GAITHERSBURG, Md. and PRINCETON, N.J., Dec. 19 /Xinhua-PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI) and BioWa, Inc. announced today that they have entered into a licensing and coll...

2006-12-19 19:00 1012

The Prestigious Scientific Journal Nature Recognizes the Scientific Work Carried out With the Research Centre of Hospital Laval and at the University Laval

Measuring waist circumference is key to assessing cardiometabolic risk QUEBEC, Dec. 15 /Xinhua-PRNewswire/ -- Today's issue of Nature (Vol # 444) summarizes in an article, signed by both Professor Jean-Pierre Despres and Doctor Isabelle Lemieux from the University of Laval, the current ...

2006-12-15 11:25 978

Landmark Study of Avastin in Lung Cancer Published Today in New England Journal of Medicine

- Avastin is First Medicine to Extend Survival Beyond One Year in Patients with Previously Untreated Non-Small Cell Lung Cancer BASEL, Switzerland, Dec. 14 /Xinhua-PRNewswire/ -- Avastin is the first medicine proven to help previously untreated patients suffering from the most common ...

2006-12-14 09:38 857